Please use this identifier to cite or link to this item:
Title: Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings
Authors: Mehta, Ushma
Clerk, Christine
Allen, Elizabeth
Yore, Mackensie
Sevene, Esperança
Singlovic, Jan
Petzold, Max
Mangiaterra, Viviana
Elefant, Elizabeth
Sullivan, Frank M.
Holmes, Lewis B.
Gomes, Melba
Keywords: Pregnancy Registry
Congenital anomaly
Congenital anomaly
Drug exposure
Birth defects
Issue Date: 1-Jan-2012
Publisher: BMC Pregnancy and Childbirth
Citation: Mehta et al.: Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings. BMC Pregnancy and Childbirth 2012 12:89
Abstract: Background: The absence of robust evidence of safety of medicines in pregnancy, particularly those for major diseases provided by public health programmes in developing countries, has resulted in cautious recommendations on their use. We describe a protocol for a Pregnancy Registry adapted to resource-limited settings aimed at providing evidence on the safety of medicines in pregnancy. Methods/Design: Sentinel health facilities are chosen where women come for prenatal care and are likely to come for delivery. Staff capacity is improved to provide better care during the pregnancy, to identify visible birth defects at delivery and refer infants with major anomalies for surgical or clinical evaluation and treatment. Consenting women are enrolled at their first antenatal visit and careful medical, obstetric and drug-exposure histories taken; medical record linkage is encouraged. Enrolled women are followed up prospectively and their histories are updated at each subsequent visit. The enrolled woman is encouraged to deliver at the facility, where she and her baby can be assessed. Discussion: In addition to data pooling into a common WHO database, the WHO Pregnancy Registry has three important features: First is the inclusion of pregnant women coming for antenatal care, enabling comparison of birth outcomes of women who have been exposed to a medicine with those who have not. Second is its applicability to resource-poor settings regardless of drug or disease. Third is improvement of reproductive health care during pregnancies and at delivery. Facility delivery enables better health outcomes, timely evaluation and management of the newborn, and the collection of reliable clinical data. The Registry aims to improves maternal and neonatal care and also provide much needed information on the safety of medicines in pregnancy. Keywords: Pregnancy Registry, Congenital anomaly, Pharmacovigilance, Teratogenicity, Drug exposure, Antiretrovirals, Antimalarials, Birth defects, Neonates, Safety, Resource-limited settings
Appears in Collections:Artigos Publicados em Revistas Cientificas - FAMED

Files in This Item:
File Description SizeFormat 
1471-2393-12-89.pdf766.98 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.